Exascale Labs Holdings (Nasdaq: XLAB) just hit the tape — Houston-based GPU-as-a-Service provider running a software-defined AI infra platform, live via SPAC merger with D. Boral ARC. Headline: FY26 r

Growth is real but the P&L is ugly: net loss widened to $12.2M from $7.7M, and gross margin sits at just 16.3%. Scaling GPU capacity at thin spreads is the core question here. Cash is the pressure point — only $2.7M on the books at June 30, 2026, plus roughly $11.8M in net proceeds from the de-SPAC close. That's a short runway for a capital-hungry business. Risk stack per the filing: GPU supply constraints, pipeline conversion, and competition from bigger, better-capitalized GPU clouds. The ~$300M qualified pipeline and ~68% renewal rate are promising but unproven — and the Compal and EnergyBank deals are non-binding. Bottom line: triple-digit revenue growth against widening losses and thin cash makes this a show-me story. Watch pipeline conversion and margin trajectory before chasing XLAB post-listing.

Growth is real but the P&L is ugly: net loss widened to $12.2M from $7.7M, and gross margin sits at just 16.3%. Scaling GPU capacity at thin spreads is the core question here.